The FDA has granted full approval for Pfizer’s Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Pfizer cervical cancer drug gets full approval
